In early October (2020), the White House announced that US President Donald Trump was given a course of remdesivir, a steroid called dexamethasone, and an experimental antibody cocktail.
An antibody cocktail is exactly what it sounds like, a mixture of two or more antibodies in a single treatment to help combat an infectious disease.
